干细胞之家 - 中国干细胞行业门户第一站

标题: The dynamics of glomerular filtration in the puerperium [打印本页]

作者: 轻羽 时间: 2009-4-22 08:16 标题: The dynamics of glomerular filtration in the puerperium

作者：M. A. Hladunewich, R. A. Lafayette, G. C. Derby, K. L. Blouch, J. W. Bialek, M. L. Druzin, W. M. Deen, and B. D. Myers作者单位：1 Division of Nephrology, Department of Medicine, and 2 Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, California 94305; and 3 Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 7 V% c% K4 {! v) T8 n

   ( B! |. y8 c( E- L3 h1 u- A

                     ) h) z/ M/ r+ T. F; I


         , P$ u& C# S, j( k( p

                  . H5 e4 n! Z- |1 ?

      + ~4 b& f" p" R+ ^7 Y3 W* a5 n
      1 v  k5 C4 {7 L7 O
      【摘要】
   We evaluated the glomerular filtration rate (GFR) during the second postpartum week in 22 healthy women who had completed an uncomplicated pregnancy. We used physiological techniques to measure GFR, renal plasma flow, and oncotic pressure and computed a value for the two-kidney ultrafiltration coefficient ( K f ). We compared these findings with those in pregnant women previously studied on the first postpartum day as well as nongravid women of reproductive age. Healthy female transplant donors of reproductive age permitted the morphometric analysis of glomeruli and computation of the single-nephron K f. The aforementioned physiological and morphometric measurements were utilized to estimate transcapillary hydraulic pressure ( P) from a mathematical model of glomerular ultrafiltration. We conclude that postpartum day 1 is associated with marked glomerular hyperfiltration ( 41%). A theoretical analysis of GFR determinants suggests that depression of glomerular capillary oncotic pressure, the force opposing the formation of filtrate, is the predominant determinant of early elevation of postpartum GFR. A reversal of the gestational hypervolemia and hemodilution, still evident on postpartum day 1, eventuates by postpartum week 2. An elevation of oncotic pressure in the plasma that flows axially along the glomerular capillaries to supernormal levels ensues; however, GFR remains modestly elevated ( 20%) above nongravid levels. An analysis of filtration dynamics at this time suggests that a significant increase in P by up to 16%, an 50% increase in K f, or a combination of smaller increments in both must be invoked to account for the persistent hyperfiltration. + W% Z8 V) K5 c, K) \& t
      【关键词】 pregnancy glomerular hemodynamics ultrafiltration coefficient transcapillary hydraulic pressure gradient
   PREGNANT WOMEN EXHIBIT MARKED glomerular hyperfiltration. During the second half of pregnancy, the glomerular filtration rate (GFR) is elevated above normal, nongravid levels by 40-60% ( 3, 14, 17, 18, 26, 45, 52, 53 ). This hyperfiltration appears to result primarily from depression of the oncotic pressure in the plasma that flows axially along the glomerular capillaries ( GC ). The latter pressure is, of course, the force that opposes the formation of glomerular filtration ( 20 ). The reduction of GC in pregnancy is attributable to two phenomena. The first is a hypervolemia-induced hemodilution that lowers the protein concentration and oncotic pressure of plasma entering the glomerular microcirculation ( 30, 47, 49, 50 ). The second is an elevated rate of renal plasma flow (RPF) ( 3, 14, 18, 52 ). An ensuing hyperperfusion of glomeruli blunts the extent to which the axial protein concentration and oncotic pressure can increase along the glomerular capillaries during filtrate formation ( 11 ).

In contrast to the gravid state, there is scant knowledge about GFR and its determinants during the puerperium. We have reported that the GFR remains elevated above normal, nongravid levels by 40% on the first postpartum (PP) day ( 38 ). Although oncotic pressure remained significantly decreased association with persistent hemodilution, the elevation of RPF observed during gestation was no longer evident at this time. Two other studies have reported that GFR remains elevated during the first PP week but is restored to nongravid levels by 1 mo after delivery ( 25, 36 ). However, these latter studies have several limitations, including suboptimal techniques for the determination of GFR and failure to evaluate any of the determinants of GFR.
8 r# d; T  x# {; f# w5 t
In addition to increasing our understanding of the physiology of the course of gestational hyperfiltration, precise knowledge of GFR and its determinants during the puerperium has implications for the evaluation of pregnancy-induced glomerular disease. Pertinent examples include preeclampsia, which may worsen, and preexisting lupus nephritis, which may flare immediately after delivery ( 4, 31, 41, 46 ). Determination of the extent to which such glomerular injuries depress the GFR requires precise knowledge of the normal range for GFR at corresponding point in time during the puerperium. To this end, we evaluated the GFR and its determinants during the second PP week in 22 healthy women completing an uneventful pregnancy. Our findings form the basis of this report.
8 Q2 K. p$ n. n1 w9 o# j
METHODS% F- f: r0 N4 I% R
: c" }: T% Y9 w! g/ q
Study Populations  E5 P2 p6 I" G2 X1 r0 b6 z  x5 o
- n, l# h. u% S( I9 h7 q% D
The experimental group was composed of 22 healthy women who had completed an uncomplicated pregnancy. Each consented to undergo a study of glomerular function that had been approved by the Institutional Review Board at Stanford University. It was conducted during the second PP week. In each case, the gestation had reached full term, 37-41 wk. A subset of seven members of the experimental group also underwent serial plasma measurements of active renin and angiotensin on three occasions: before delivery during the third trimester, on the second or third PP day, and with the renal function study (PP week 2 ).5 F2 I9 w2 e% |( B

As stated above, we have previously reported the findings in 12 healthy mothers undergoing a study of glomerular function after uncomplicated pregnancy on PP day 1 ( 38 ). They serve in the present study as a comparison group for the findings in our experimental group.

Two groups of healthy female volunteers of reproductive age (20-48 yr) served as nongravid controls. One group of 40 women underwent the same study of glomerular pressures and flows as our experimental group. These subjects served as functional nongravid controls. A separate group was composed of 12 living kidney transplant donors who underwent biopsy at the time of transplantation. Glomeruli in the biopsy core were subsequently subjected to a morphometric analysis of glomerular structure. These subjects served as structural nongravid controls. Formal studies of glomerular pressures and flows were not undertaken in the structural control group. However, each was meticulously investigated for possible renal abnormalities before kidney donation, and all were found to have a normal creatinine clearance.; r; ]2 s+ J$ N0 O$ h8 m9 `7 r6 R" \

All 86 subjects in our experimental, comparison, and control groups denied a history of renal disease, hypertension, or diabetes mellitus. During the pregnancy that preceded the PP studies and at the time of each evaluation, each subject was found to be normotensive and normoglycemic and to have normal levels of serum creatinine and urinary protein.

Physiological Evaluation8 ?; ^' S/ }. s( K# |& B* n: w' Q7 ]
3 y2 J2 F  T( L
Women in the experimental and comparison groups and functional nongravid controls were admitted to the General Clinical Research Center at Stanford University Medical Center. The subset of the experimental group undergoing renin and angiotensin assays maintained an upright posture for 30 min before blood samples were drawn. All subjects had blood drawn for a baseline determination of plasma afferent oncotic pressure ( A ) and Hct. Urine was voided spontaneously after diuresis had been established with an oral water load (10-15 ml/kg). A priming dose of inulin (50 mg/kg) and PAH (12 mg/kg) was then administered. Thereafter, inulin and PAH were given by continuous infusion to maintain plasma levels constant at 20 and 1.5 mg/dl, respectively.1 E, z) r1 Y/ L) z0 i  q6 Z0 t1 p8 d) z
1 M6 b& V& L! x
Sixty minutes after the priming infusion, arterial blood pressure was determined. Four timed urine collections were then made, each of which was bracketed by a blood sample drawn from a peripheral vein. The GFR was expressed as the average value for the four timed inulin clearances. The rate of RPF was estimated by dividing the corresponding clearance of PAH by an assumed renal arteriovenous extraction ratio for PAH of 0.9, a value that we and others have shown to be typical of the healthy kidney in both the gravid and the nongravid state ( 6, 12, 58 ). Both GFR and RPF were adjusted for body surface area as determined from height and weight measured at the first obstetrical visit. Inulin and PAH concentrations were determined with colorimetric methods using a Technicon Auto Analyzer II ( 6 ). Plasma oncotic pressure was measured directly using a Wescor 4400 membrane osmometer (Wescor, Logan, UT).4 Q; z# c) q0 B! i

Both plasma active renin and angiotensin levels were determined by radioimmunoassay (kit 40-6050, Nichols Institute Diagnostics, San Juan Capistrano, CA, and kit 001-RK-A22, Alpco Diagnostics, Windham, NH, respectively). Differences in plasma volume from the third trimester to the second or third PP day and to the renal function study (PP week 2 ) were calculated using the equation* D; c4 d. f) I2 j/ n$ H2 E
% E! U; |! ?) k6 A  M) c
where Hct 1 is the Hct predelivery, and Hct 2 is either the Hct in the early PP period or during PP week 2.% s. K% V; r% `0 j8 Y

Morphometric Evaluation* Q1 e3 x6 u) Q3 m: N7 k
' E( {, A+ w3 Y% O& U& o( E
Light microscopy. Two cores of renal tissue were taken by open biopsy from the structural nongravid controls. The biopsy was taken immediately before the renal blood supply was clamped and the kidney was removed for transplantation. All glomeruli in a single, 1-µm-thick section stained with periodic acid Schiff reagent were analyzed at the light microscopic level. On average, 19 (range, 5-58) glomeruli were examined. A dedicated computer system (Southern Micro Instruments, Atlanta, GA), consisting of a video camera and monitor, microscope, and digitizing tablet, was used to perform the measurements. The outline of each glomerular tuft in the section was traced onto the digitizing tablet and the mean tuft cross-sectional area was determined using computerized planimetry. Glomeruli that had undergone global sclerosis were rare (

where is a dimensionless shape coefficient ( = 1.38 for spheres), d is a size distribution coefficient ( d = 1.1), which is used to adjust for variations in glomerular size ( 57 ), and f is a correction factor for the tissue shrinkage associated with paraffin embedding ( f s = 1.64) ( 44 ).
# t1 V, o2 j6 R* ?
Electron microscopy. For transmission electron microscopy, tissue was fixed in 2.5% glutaraldehyde and 2.0% paraformaldehyde in 0.1 M cacodylate buffer and then embedded in Epon. Toluidine blue-stained sections were surveyed to locate blocks with patent glomeruli present entirely within the block. An ultrastructural analysis was performed on two glomerular profiles in each patient. Ultrathin sections ( 90 nm) of the selected glomeruli were stained with lead citrate and uranyl acetate. A complete montage of each glomerulus ( x 2,850 magnification) was prepared, and line-intercept counting was used to calculate the fractional surface density of the peripheral capillary wall by standard stereological methods ( 57 ). Six to eight images of peripheral capillary loops in each of the glomerular profiles were then photographed at x 11,280 to evaluate the frequency of epithelial filtration slits and the thickness of the peripheral glomerular basement membrane. Filtration slit frequency was determined by counting the total number of epithelial filtration slits and dividing that number by the total length of the peripheral capillary wall at the epithelial interface ( 23 ). The harmonic mean basement membrane thickness ( bm ) was calculated for each individual using the method of orthogonal intercepts ( 34 )
1 S8 A/ ], a% \5 ]
where bm' is the apparent harmonic mean basement membrane thickness.

Theoretical Analysis' P' L) v7 [- Z$ O% W
; a, {2 W" E) l' o
The relationship between GFR and its determinants was assessed using the following equation7 Y! {! z; b1 d2 p' ^( r

where P is the transcapillary hydraulic pressure difference, GC is the mean glomerular intracapillary oncotic pressure, and K f is the glomerular ultrafiltration coefficient, i.e., the product of hydraulic permeability ( k ) and filtration surface area ( S ). To compute GC, we first calculated oncotic pressure of plasma entering the efferent arteriole from the glomerular tuft ( E )
6 B6 C" \9 O# I$ v& p
where A is afferent oncotic pressure, and FF is the filtration fraction. Equation 5 assumes that oncotic pressure rises linearly during axial plasma flow along the glomerular capillary loops, an assumption that we have shown previously to be accurate within 0.5 mmHg ( 13 ). We then calculated GC as the mean of A and E ( 13 ). We next estimated the K f for two kidneys as follows  H. H! b3 ]# c" R5 X1 Q- ^* w

where 1.4 x 10 6 is the most accurate assessment available of the mean number of glomeruli in women with healthy kidneys between the ages of 20 and 50 yr ( 48 ), and SN K f is computed from the above-described morphometric analysis of glomeruli in our structural nongravid controls.

The total filtration surface area in a single glomerular tuft ( S ) was calculated from

where S v and V G are, respectively, the filtration surface density and glomerular tuft volume. In making this calculation, we corrected for the effect of immersion fixation to decrease glomerular dimensions relative to in situ perfused glomeruli ( 44 ). The intrinsic hydraulic permeability ( k ) of the glomerular capillary wall was then estimated from the filtration slit frequency (FSF) and the basement membrane thickness by using a hydrodynamic model of viscous flow that has been described in detail elsewhere ( 19, 23 ). Finally, SN K f was calculated from the product of k and S ( 23 ).

We then assumed that, as in the normal rat, K f does not change during pregnancy ( 7, 8 ), and extrapolated the computed value for K f from our structural nongravid controls to our comparison and experimental puerperal groups. To take into account the possibility that pregnancy and the puerperium in humans might be associated with glomerular enlargement, we also performed a sensitivity analysis using larger values for V G in calculating S from Eq. 7. To the best of our knowledge, there are no reported determinations of V G in normal pregnancy. We accordingly assumed that V G in normal pregnancy might enlarge by 50 or 100% and recalculated S to provide a range of values and a likely upper bound for our computation of K f in the two puerperal groups in the present study.
/ r& [- {9 N* m. l1 O0 N5 z* b
Finally, based on our determinations of GFR and GC and our estimate of K f, we rearranged Eq. 4 to compute P, the only remaining determinant of GFR. To estimate P from the three aforementioned quantities, we utilized a modification of the mathematical model of glomerular ultrafiltration of Deen et al. ( 20 ), which is described in detail elsewhere ( 1 ).9 T* ], [8 E. M2 K/ x7 p
1 R0 t# {; d* m
Statistical Analysis

To assess the significance of differences among the experimental, comparison, and control groups, we conducted three-way comparisons using ANOVA or the Kruskal-Wallis test. Either the Student-Newman-Keuls test or the Dunn procedure was used to make the respective post hoc comparisons. A repeated-measures design was utilized to assess for differences in the serum active renin and angiotensin levels before delivery, the early PP period, and PP week 2. All results are expressed as the means ± SD with the exception of the computed value for P, which was expressed as the median (and 95% confidence interval). Proportions were compared using the 2 test statistic or Fisher exact test where appropriate. SAS (version 8.0) and NCSS/PASS statistical software were utilized.: T& V, n& c) \; z3 A  n6 J
/ k* N4 n0 a' S5 \
RESULTS

The observed range of GFR values is illustrated in Fig. 1. There was little overlap between the nongravid control and PP day 1 comparison groups. On average, GFR in puerperal subjects on PP day 1 exceeded corresponding nongravid control values by 42%, 149 ± 33 vs. 105 ± 15 ml·min -1 ·1.73 m 2, respectively ( P = 0.01; Table 1 ). GFR in the experimental group in PP week 2 remained elevated above the control nongravid value, averaging 125 ± 29 ml·min -1 ·1.73 m 2 ( P = 0.01). As shown in Fig. 1 A, the distribution in PP week 2 GFR was shifted toward the lower end of the PP day 1 range, resulting in a significant lowering of GFR below PP day 1 levels ( P = 0.01; Table 1 ).$ ?1 r! \8 u' z( R" M
( V' D7 ]; o4 A, Q0 g# S  F, T
Fig. 1. Box plots comparing the glomerular filtration rate (GFR; A ) and the glomerular oncotic pressure ( GC; B ) in nongravid controls ( left ), postpartum (PP) patients studied on day 1 ( middle ), or during PP week 2 (wk2; right ). * P 1 U6 E6 L6 L' i  I( h4 f( L7 i
0 l6 u" T' G( v6 [
Table 1. Clinical characteristics5 N5 c; F9 k9 P7 z
) c# p; H; ?# u# f' U5 J
Several clinical features that bear on glomerular filtration are summarized in Table 1. Both ethnic distribution and calculated body surface area were similar in the three groups. Although age was similar in the two gravid groups, it was significantly higher than that of our functional nongravid controls and lower than that of our structural controls. Whereas determination of the creatinine clearance in healthy populations has suggested that the GFR begins to decline after age 20-30 yr ( 39, 56 ), studies that utilized inulin clearance to determine GFR reveal that the GFR does not exhibit a measurable age-related decline until after age 50 ( 5, 16, 22, 28, 59 ). Thus the disparity in age between the PP patients and nongravid controls is unlikely to be of biological significance. Although it tended to be lower PP, mean arterial pressure did not differ significantly among the three groups ( Table 1 ). A parallel reduction in Hct and serum albumin concentrations below nongravid control levels is consistent with the persistence of gestational hypervolemia on PP day 1 ( 10, 32, 55 ). A parallel increase in Hct and serum albumin concentrations above the corresponding early PP levels in the experimental group by PP week 2 restored these values toward the nongravid control range, a change consistent with a 19% reduction in plasma volume between early PP and PP week 2 ( Fig. 2 ).! b9 W6 K4 @/ H9 |

Fig. 2. Percent change in plasma volume ( P) from predelivery to the early PP period ( left ) and from the early PP period to PP week 2.

Glomerular Filtration Dynamics+ o( X% E; m7 v. Q! i0 {: d
/ ~" b+ y7 ~0 z: [; y$ }" \
Glomerular pressures and flows are summarized in Table 2. The hypervolemia on PP day 1 was associated with a trend toward higher RPF, 624 ± 108 vs. 560 ± 130 ml·min -1 ·1.73 m 2 in nongravid controls ( P = not significant; Table 2 ). The subsequent contraction of plasma volume was accompanied by a significant reduction in RPF below PP day 1 levels to 514 ± 109 ml·min -1 ·1.73 m 2 in PP week 2 ( P = 0.05 vs. PP day 1; Table 2 ). The disproportionate increase in GFR relative to RPF on PP day 1 and selective elevation of GFR on PP week 2 resulted in filtration fractions at both time points in the puerperium (0.24 ± 0.05 and 0.25 ± 0.06%, respectively) that were significantly elevated above the control nongravid value (0.19 ± 0.04%; Table 2 ).
& ^3 g/ H4 I: o8 b- p9 s9 I' }9 d
Table 2. Filtration dynamics. H  z( P& g9 Q0 j
3 t7 \  |1 I" W6 m! I1 `- d
Differences in A among the three groups parallel those summarized in Table 1 for serum albumin concentration. The PP day 1 hypoalbuminemia was accompanied by a 7 mmHg mean reduction in measured A, which averaged only 17.6 ± 1.3 vs. 24.3 ± 2.2 mmHg in nongravid controls ( P = 0.005). Both serum albumin and A (24.7 ± 1.7 mmHg) were largely restored by PP week 2 to normal nongravid values (Tables 1 and 2 ). Despite the elevated filtration fraction, the computed value for GC was also significantly lower in PP day 1 subjects than in nongravid controls, 20.4 ± 1.7 vs. 27.1 ± 2.3 mmHg, respectively ( P = 0.005; Fig. 1 B, Table 2 ). On the other hand, the persistent elevation of the filtration fraction along with near normalization of the serum albumin in puerperal subjects in PP week 2 resulted in a significant elevation of GC above PP day 1 levels to 28.9 ± 2.3 mmHg ( P = 0.05, Fig. 1 B, Table 2 ). Thus an increase in the pressure opposing the formation of filtrate presumably contributed to the significant reduction observed in GFR between PP day 1 and week 2 but was insufficient to prevent persistence of hyperfiltration of a moderate magnitude during PP week 2 ( Table 1, Fig. 1 A ).8 C" w$ @3 \  t! n: I5 l
  G' }$ o4 t/ }, \3 P
Theoretical Analysis of K f and P/ f$ k6 }2 Q8 p0 l) L

Given the elevation of GC above nongravid levels during PP week 2, the persistent elevation of GFR above nongravid levels by 20% at this time could only result from a corresponding elevation of either K f and/or P (see Eq. 4 ). In an attempt to evaluate a possible contribution by P, we first used the morphometric analysis of glomeruli in our structural nongravid controls to estimate a likely lower limit for gestational single-nephron K f. Mean V G was 2.24 ± 1.09 µm 3 x 10 6, and filtration surface density was 0.12 ± 0.03 µm 2 /µm 3. The product of these two quantities yielded a value for S of 4.09 ± 1.22 µm 2 x 10 5 /glomerulus ( Eq. 7 ). Glomerular basement membrane thickness averaged 373 ± 37 nm, and the frequency of filtration slits was 1,265 ± 190 slits/mm of glomerular basement membrane length. Applying these quantities to our hydrodynamic model of viscous flow, we estimate k to be 4.1 ± 0.6 m·s -1 &middot

a -1 x 10 -9. The product of S x k yields a nongravid control value for single-nephron K f of 6.13 nl/(min·mmHg), and Eq. 6 yields a corresponding value for two-kidney K f of 8.58 ml/(min·mmHg).

The range of values computed for P in nongravid controls ( Fig. 3, left ) and the PP day 1 and PP week 2 puerperal groups ( Fig. 3, center and right, respectively) are illustrated in Fig. 3. In each group, the measured values for GFR, RPF, and A have been used to compute P along with the estimated value for K f in the structural nongravid control group. The box plots illustrate that the computed range for P in the two puerperal groups is 1 ) far broader than in controls and 2 ) exhibits a non-Gaussian distribution. The controls are computed to have a median value (and 95% confidence interval) of 41.6 (39.8-42.9) mmHg. The PP day 1 comparison group has a similar median value of 42.1 and a 95% confidence interval of 34.2-42.6 mmHg (Table 5; P = not significant). In contrast, the PP week 2 experimental group is computed to have a significant increase in P to 43.5 (42.6-49.9) mmHg (Table 5; P 5 G# P9 ?: D) N0 g' M- M
& _$ d, w& B0 `# i* u% W# k
Fig. 3. Box plots comparing the calculated P in nongravid controls ( left ), patients studied on PP day 1 ( middle ), and patients studied during the PP wk2 ( right ) where: * P . g, z" x1 Z: F4 u" w- R3 t* {

Table 3 also provides hypothetical values for P in the event that the puerperium is associated with an increase in V G by either 50 or 100%, and hence in K f, above control values. Each of the higher assumed K f values lowers P significantly below control values on PP day 1. However, given the diminished oncotic pressure on PP day 1, the modeled median P of 35.3 mmHg (with a 50% increase in K f ) is sufficient to maintain a higher net filtration pressure than calculated for the control population. By PP week 2, the higher assumed K f input values also lower P. Neither the 50 nor the 100% increase in K f lowers P values significantly below control values, however. Moreover, for each of the three levels of K f assumed for purposes of this sensitivity analysis, the computed P in PP week 2 exceeds the corresponding value on PP day 1 ( Table 3 ). Thus either an isolated increase in P by 5-15% above control values or an isolated corresponding elevation in K f by 50% can be invoked to explain the persistent glomerular hyperfiltration relative to nongravid control values in PP week 2.

Table 3. Modeled P values
2 k5 L2 p! T/ J$ w; I! [9 ]
The aforementioned computations suggest that some elevation of P could have contributed to persistent hyperfiltration during PP week 2. The combination of a decline in RPF along with an elevation of P and the filtration fraction is consistent with stimulation of the renin-angiotensin system by plasma volume contraction during the PP period ( 40 ). However, serial measurements of plasma concentrations of active renin and angiotensin in a subset of the experimental group may not support this as a possible explanation. Plasma active renin before delivery was 51 ± 17 µU/ml. This level declined to 29 ± 9 µU/ml in the early PP and increased only slightly to 36 ± 11 µU/ml during PP week 2. Both PP values were significantly lower than the predelivery values ( P
. L* V# m! u# j9 _5 o
Table 4. Serial active renin and angiotensin plasma levels3 ^. B+ I0 C/ U9 B+ X9 |

DISCUSSION
5 n  d3 X' d" g) D, U# M
Studies of human pregnancy that have employed the most reliable filtration marker, inulin, have demonstrated that GFR increases progressively during the first half of pregnancy. It then reaches a peak level that exceeds nongravid levels by 40-60%, after which it remains constant until the end of pregnancy ( 3, 14, 17, 18, 26, 45, 52, 53 ). As judged by the comparison group in the present study, this level of hyperfiltration persists into the first PP day ( 38 ). As judged by our experimental group, hyperfiltration of lesser magnitude (±20%) then persists into the second PP week ( Fig. 1 A, Table 2 ).& g$ B( Y8 u* @* C0 g. o

The GFR can be equated with the product of K f and the net pressure for ultrafiltration, i.e., P - GC ( Eq. 4 ). Determinations of RPF, filtration fraction, and A during peak gestational hyperfiltration in late pregnancy and on PP day 1 reveal that GC is depressed by between 3.3 and 6.7 mmHg ( 38, 45, 52 ). In the event that neither P nor K f is altered by gestation, an equivalent increase in the net pressure for ultrafiltration could account exclusively for the observed level of hyperfiltration. However, Milne and co-workers ( 45 ) have recently interpreted an alteration in the transglomerular sieving of uncharged dextran macromolecules of broad size distribution to indicate that, in addition to depression of GC by 3.3 mmHg, an 15% increase in K f is required to account for the 38% increase in GFR observed by them in late pregnancy.* S3 R) p$ a/ |2 e) f! i

Because of technical shortcomings, notably the large coefficient of variation in measured dextran sieving coefficients, the precision of the aforementioned analysis by Milne et al. should be interpreted with caution ( 45 ). Another possible source of imprecision in the aforementioned study is that oncotic pressure in plasma was not measured directly by membrane osmometry but was calculated from serum protein concentration using an equation based on the relationship between this quantity and oncotic pressure in the rat ( 45 ). We have shown that the foregoing relationship fails to predict oncotic pressure in human plasma accurately ( 13 ). In addition to the consideration of species differences between rats and humans, we note with interest that the relationship may be altered by pregnancy. For example, there is a disparity between gestational plasma albumin concentration and oncotic pressure in the experimental group of the present study. Whereas measured A is almost identical to that in controls, 24.7 ± 1.7 vs. 24.3 ± 2.2 mmHg ( Table 2 ), the corresponding serum albumin is significantly lower, 3.2 ± 0.3 vs. 3.9 ± 0.5 g/dl ( Table 1 ). This suggests that pregnancy and the PP state alter the plasma protein composition, such that elevated levels of circulating proteins other than albumin contribute to the prevailing oncotic pressure ( 50 ). As demonstrated by us previously for the nephrotic syndrome, we submit that attempts to calculate oncotic pressure from protein concentration using equations that do not take alterations in protein composition into account are likely to be inaccurate ( 13 ).
+ f1 F4 c1 ?/ Q1 L& l  Z7 v
Baylis ( 7, 8 ) has used the micropuncture technique to examine the determinants of peak hyperfiltration in the pregnant rat. Among the determinants of GFR, she observed a significant change only in RPF, which was markedly elevated. A and P failed to change significantly ( 7, 8 ). Because the rats in Baylis's studies were at filtration pressure equilibrium, unique values of K f could not be calculated, and conclusions about the elevation of K f could not be drawn. Evidence that K f elevation may nevertheless be implicated in hyperfiltration is provided by a more recent micropuncture study, in which Baylis compared filtration dynamics in gravid vs. nongravid rats with a remnant kidney ( 21 ). As in healthy pregnant rats, higher plasma flow and similar levels of oncotic pressure accompanied remnant hyperfiltration. However, an effect of pregnancy to reduce the hypertension associated with the remnant kidney model resulted in a P value that was 10 mmHg lower than in nongravid remnant kidney rats. Because this experimental model is associated with filtration pressure dysequilibrium, Baylis was able to calculate a unique value for K f. She reported a greater than twofold increase in this quantity, which accounted for the hyperfiltration in the pregnant animals, suggesting that K f elevation could well be implicated in gestational hyperfiltration.

From the available evidence, we contend that a role for alteration of any GFR determinants other than depressed GC in peak gestational hyperfiltration in humans is ambiguous. However, an examination of Eq. 4 reveals that elevation of either P or K f, or a combined elevation of both, may be implicated in the hyperfiltration that is observed in the first half of pregnancy ( 14 ) and during PP week 2. The hemodilution-induced fall in GC during the second trimester is far smaller than in the third trimester. From the findings of Roberts et al. ( 52 ), the estimated reduction of A at 16 wk of gestation was by only 1.1 mmHg. We compute the corresponding depression of GC to be only 1.5 mmHg, despite a large increase in RPF. This suggests that increases in P and/or K f must be invoked to explain the corresponding elevation of GFR by 48% ( 52 ).
, b& _6 U2 `" a6 v/ ^
More certain is that only elevation of P and/or K f can explain the persistent hyperfiltration by 20% in PP week 2 in the present study. A sharp drop in plasma volume resulted in a reversal of hemodilution ( Table 1 ). As a result, GC actually exceeded the corresponding control value significantly, 28.9 ± 2.3 vs. 27.1 ± 2.3 mmHg, respectively ( Fig. 1 B, Table 2 ). In attempting to distinguish a role for P elevation, we have used a modification of the mathematical model of glomerular ultrafiltration by Deen et al. ( 1, 20 ). We determined values for GFR and GC and estimated a likely range of values for K f. We subsequently rearranged Eq. 4 to yield the resulting value for P.
- Q" W/ c' ^, W+ ~8 L7 _* c
To the best of our knowledge, no determination of glomerular volume has been made during normal pregnancy. However, given the demonstration of increased kidney size during pregnancy ( 29 ), we have considered the possibility that glomeruli may hypertrophy with an attendant increase in filtration surface area and hence, K f. We thus selected a hypothetical upper limit for glomerular volume that is twofold larger than the corresponding value in healthy age-matched women. Our selection was based on a glomerular volume of 5.23 ± 2.16 µm 3 x 10 6 observed by us in pregnant women with preeclampsia, a value 2.3-fold larger than the corresponding value in the structural control group in the present study ( 37 ). Our preeclamptic subjects also exhibited considerable endocapillary cell proliferation and hyperplasia, more markedly in glomerular endothelial than mesangial cells ( 37 ). We surmise that the expansion of the endocapillary cell compartment must have contributed significantly to the glomerular enlargement. Any glomerular hypertrophy that might be attributable to normal pregnancy alone is of substantially smaller magnitude and thus in all likelihood, by less than a factor of 2.0. Our sensitivity analysis reveals that an increase of K f by 50% or more can account exclusively for the maintenance of the increased GFR by 20% in postpartum week 2 ( Table 3 ). Alternatively, should a gestational increase in K f not eventuate in humans, an isolated elevation of P by up to 16% above the normal range must be invoked to explain the persistent elevation of GFR in PP week 2 ( Table 3 ).5 a4 Y- w8 }- [9 u( ?
9 ~  D0 B; ~' B. O" \5 \; a
During the present study, we observed that plasma volume declines sharply between early PP and PP week 2. We accordingly proceeded to study the circulating renin-angiotensin system serially in a subset of our experimental group. We wished to test the hypothesis that stimulation of this system in response to plasma volume contraction might lead to efferent arteriolar vasoconstriction and thereby explain the decline in RPF along with a possible elevation of calculated P. Paradoxically, however, active renin and angiotensin levels in plasma declined during the puerperium ( Fig. 2 and Table 4 ). Nevertheless, it remains possible that enhanced angiotensin II action led to efferent arteriolar vasoconstriction in PP week 2. Decreased vascular sensitivity to the pressor effects of angiotensin during pregnancy has been well documented ( 9, 33, 42, 51 ). A possible mechanism includes alteration to receptor number and/or affinity ( 27 ). Animal data support the possibility that vascular responsiveness to angiotensin is restored by the PP day 5 ( 15, 35, 43 ). Thus one possibility is that the resistance to angiotensin II that is observed in pregnancy may have resolved by PP week 2, with the result that angiotensin action was enhanced despite low ambient levels in plasma. Another possibility is that PP week 2 was accompanied by a paradoxical stimulation of a paracrine, intrarenal renin-angiotensin system, notwithstanding an opposite trend in the systemic circulation ( 2 ). It is worthy of note that angiotensin I infusion has been shown in the rat to lower K f modestly (
2 l! \3 [& }* m9 U) M
To summarize, we conclude that PP day 1 is associated with marked glomerular hyperfiltration ( 41%) comparable in magnitude to peak levels reported in the second half of pregnancy. A theoretical analysis of GFR determinants suggests that depression of GC is predominantly or exclusively responsible for early elevation of PP GFR. A reversal of the gestational hypervolemia and hemodilution, still evident on PP day 1, eventuates by PP week 2. An elevation of GC to supernormal levels ensues, yet GFR remains modestly elevated ( 20%) above nongravid levels. An analysis of filtration dynamics at this time suggests that either a significant increase in P by up to 16%, an 50% increase in K f, or a combination of smaller increments in both P and K f must be invoked to account for the persistent hyperfiltration. PP depression of plasma renin and angiotensin levels points away from, but does not exclude, a glomerulopressor effect of this system as a possible mediator of the glomerular hyperfiltration that persists into the PP week 2.
: E1 G0 @' b3 h% \6 M5 l' A
GRANTS  L1 P$ I9 S4 B5 E# S1 e7 ^1 d

This study was supported by National Institutes of Health Grant DK-52876 and General Clinical Research Center Grant M01-RR-00070. M. Hladunewich's postdoctoral fellowship was supported by the Satellite Dialysis Centers Postdoctoral Fellowship and Education Fund and by the Northern California Chapter of the National Kidney Foundation.
      【参考文献】
Alejandro V, Scandling JD Jr, Sibley RK, Dafoe D, Alfrey E, Deen W, and Myers BD. Mechanisms of filtration failure during postischemic injury of the human kidney. A study of the reperfused renal allograft. J Clin Invest 95: 820-831, 1995.

" R! o' L$ Y. S" W" D9 j- b; C
" ?" Y* Q  C. z0 L4 _
Anderson S. Role of local and systemic angiotensin in diabetic renal disease. Kidney Int Suppl 63: S107-S110, 1997.

3 J, K9 ^8 D8 O: @: |
Assali NS, Dignam WJ, and Dasgupta K. Renal function in human pregnancy. II. Effects of venous pooling on renal hemodynamics and water, electrolyte and aldosterone excretion during normal gestation. J Lab Clin Med 54: 394-408, 1959.

Atterbury JL, Groome LJ, Hoff C, and Yarnell JA. Clinical presentation of women readmitted with postpartum severe preeclampsia or eclampsia. J Obstet Gynecol Neonatal Nurs 27: 134-141, 1998.
0 J- s2 d- c1 ]
3 }4 x% K1 @, T' A' v

Bafitis H and Sargent F II. Human physiological adaptability through the life sequence. J Gerontol 32: 402-410, 1977.
: w+ I9 z$ B- R7 f
4 b; n/ o# T6 }9 \7 F- v

Battilana C, Zhang HP, Olshen RA, Wexler L, and Myers BD. PAH extraction and estimation of plasma flow in diseased human kidneys. Am J Physiol Renal Fluid Electrolyte Physiol 261: F726-F733, 1991.

5 l4 B6 X" {  s. }( O/ u3 a

Baylis C. Glomerular ultrafiltration in the pseudopregnant rat. Am J Physiol Renal Fluid Electrolyte Physiol 243: F300-F305, 1982.

& v7 ?5 S9 s+ ?2 f
: m! P. y, z( d! [' {9 T1 O; A
Baylis C. The mechanism of the increase in glomerular filtration rate in the twelve-day pregnant rat. J Physiol 305: 405-414, 1980.
' p+ t9 x/ a2 C, s+ W- q0 T

Benjamin N, Rymer J, Todd SD, Thom M, and Ritter JM. Sensitivity to angiotensin II of forearm resistance vessels in pregnancy. Br J Clin Pharmacol 32: 523-525, 1991.0 J- h; E: S: [9 Y$ q, s3 G
* L2 [) T* h8 ]+ R

Bernstein IM, Ziegler W, and Badger GJ. Plasma volume expansion in early pregnancy. Obstet Gynecol 97: 669-672, 2001.

5 g, ]* Z: C* m/ N# p

Brenner BM, Troy JL, Daugharty TM, Deen WM, and Robertson CR. Dynamics of glomerular ultrafiltration in the rat. II. Plasma-flow dependence of GFR. Am J Physiol 223: 1184-1190, 1972.

2 C2 S) C0 }& T/ ^$ x! H. E
Bucht H. Studies in renal function in man. Scand J Clin Lab Invest 3: 1-55, 1951.
2 d& x8 o& ^3 T3 M1 M, W5 {0 R6 j

Canaan-Kuhl S, Venkatraman ES, Ernst SI, Olshen RA, and Myers BD. Relationships among protein and albumin concentrations and oncotic pressure in nephrotic plasma. Am J Physiol Renal Fluid Electrolyte Physiol 264: F1052-F1059, 1993.
6 J& i4 j! N1 h" C7 |7 E

- o+ C5 r" W% Z% Q6 t: h3 E
Chapman AB, Abraham WT, Zamudio S, Coffin C, Merouani A, Young D, Johnson A, Osorio F, Goldberg C, Moore LG, Dahms T, and Schrier RW. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int 54: 2056-2063, 1998.0 A6 o- ~4 }$ O, E0 d1 Z

Cox BE, Ipson MA, Shaul PW, Kamm KE, and Rosenfeld CR. Myometrial angiotensin II receptor subtypes change during ovine pregnancy. J Clin Invest 92: 2240-2248, 1993.; y6 |$ D2 O, d8 S
+ P$ C; f' s+ V, }0 A

# D% z( C8 S+ q  [& u. l7 w
Davies DF and Shock NW. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest 29: 496-507, 1950.

( J: D' `5 L7 E
Davison JM and Dunlop W. Renal hemodynamics and tubular function normal human pregnancy. Kidney Int 18: 152-161, 1980.

0 m( s% M  E, F/ B% L, f% G( E& \, D
! Z, A) X4 y) s1 W& z
De Alvarez RR. Renal glomerular tubular mechanisms during normal pregnancy. I. Glomerular filtration rate, renal plasma flow and creatinine clearance. Am J Obstet Gynecol 75: 931-944, 1958.

) w9 D4 F4 M6 U6 p( C- I
2 n! ~( F5 e' u  d& w
Deen WM, Lazzara MJ, and Myers BD. Structural determinants of glomerular permeability. Am J Physiol Renal Physiol 281: F579-F596, 2001.6 I0 y8 f# k1 o" {& h' N

5 e" F; Q, A) j( L
Deen WM, Robertson CR, and Brenner BM. A model of glomerular ultrafiltration in the rat. Am J Physiol 223: 1178-1183, 1972.6 V% [7 u4 k% ]8 k$ C
. Y- m& z+ @! z3 A! c8 H* G: r! o

Deng A and Baylis C. Glomerular hemodynamic responses to pregnancy in rats with severe reduction of renal mass. Kidney Int 48: 39-44, 1995.0 t! v% R" D6 C0 u0 t4 O

' R' h4 q% ~) w1 S
- V  Q4 B9 z% p* H
DeSanto NG, Anastasio P, Coppola S, Barba G, Jadanza A, and Capasso G. Age-related changes in renal reserve and renal tubular function in healthy humans. Child Nephrol Urol 11: 33-40, 1991.
% T0 i0 Z: A7 w- c" L0 s) v; F! m

Drumond MC, Kristal B, Myers BD, and Deen WM. Structural basis for reduced glomerular filtration capacity in nephrotic humans. J Clin Invest 94: 1187-1195, 1994.2 r1 b0 Z$ V& Q* H6 I8 W$ g. c6 d

; p; M+ d% j* S8 u" O! ~; O. x8 F! y) @

Edwards A and Deen WM. Error propagation in the estimation of glomerular pressure from macromolecule sieving data. Am J Physiol Renal Fluid Electrolyte Physiol 268: F736-F745, 1995.
4 `& A: V, D! p1 J1 Z+ c6 b

1 R: I2 V# z6 x& b6 p* B1 f, r! D
El-Mahallawi MN, el-Din DS, Mahran M, Sabour MS, and Fadel HE. Glomerular filtration rate in normal pregnancy and early postpartum period. Obstet Gynecol 31: 621-626, 1968.

0 h# T7 Q/ |- F" O* z7 G" a/ |6 n
) b+ g0 |8 e8 k; n8 J; Z/ X5 J! u1 i
Ezimokhai M, Davison JM, Philips PR, and Dunlop W. Non-postural serial changes in renal function during the third trimester of normal human pregnancy. Br J Obstet Gynaecol 88: 465-471, 1981.
: u! V% [7 s5 x; I# N3 d0 S; |
" q+ a$ g& n+ H: W% J  d+ A

Gant NF, Whalley PJ, Everett RB, Worley RJ, and MacDonald PC. Control of vascular reactivity in pregnancy. Am J Kidney Dis 9: 303-307, 1987.+ L* p) D- y) c' ^2 F0 ^/ f

1 F5 _# ?* h; t: I* |
  ~& I" U0 r, G( }  ?
Hoang K, Tan JC, Derby G, Blouch KL, Masek M, Ma I, Lemley KV, and Myers BD. Determinants of glomerular hypofiltration in aging humans. Kidney Int 64: 1417-1424, 2003.

, B2 D7 ?6 w. A. M3 X
2 b4 y. a, r6 `# ~5 ?. o
Hodson CJ. Radiographic kidney size. In: Renal Disease, edited by Dak B. Oxford, UK: Blackwell Scientific, 1968, p. 136.

' ]' V. d) h: ^5 i& e; ~

Honger PE. Albumin metabolism in normal pregnancy. Scand J Clin Lab Invest 21: 3-9, 1968.

' G4 ?7 t0 M8 {! h
9 B6 v4 K( ]7 q( a* s6 c6 D7 \: @
Huong DL, Wechsler B, Vauthier-Brouzes D, Beaufils H, Lefebvre G, and Piette JC. Pregnancy in past or present lupus nephritis: a study of 32 pregnancies from a single centre. Ann Rheum Dis 60: 599-604, 2001.

; P+ D! {' ~7 f, v) o
$ L, k3 [+ C3 b; `  @& o1 b
Hytten FE and Paintin DB. Increase in plasma volume during normal pregnancy. J Obstet Gynaecol Br Commonw 70: 402-407, 1963.$ t9 Z. s* l/ Q. g

: A1 J2 j$ x' q7 y* ~% i
Ito M, Nakamura T, Yoshimura T, Koyama H, and Okamura H. The blood pressure response to infusions of angiotensin II during normal pregnancy: relation to plasma angiotensin II concentration, serum progesterone level, and mean platelet volume. Am J Obstet Gynecol 166: 1249-1253, 1992.* m* v% M6 _& l5 a' O

+ h# k) _3 R2 x3 J6 I3 }5 a0 ^
Jensen EB, Gundersen HJ, and Osterby R. Determination of membrane thickness distribution from orthogonal intercepts. J Microsc 115: 19-33, 1979.
, n4 J: ~! V6 p- q7 F" W
4 Z3 O: I, |2 S4 m! \8 w: y

Katz M and Creasy RK. Blood pressure and pressor response to angiotensin II during pregnancy and nursing in the rabbit. Gynecol Obstet Invest 12: 211-219, 1981./ g0 C! @1 S2 ^
" g: q& m% |* X2 J3 z
$ j5 Q. r% }+ x& t
4 _  P0 P- U4 T/ J2 K
Krutzen E, Olofsson P, Back SE, and Nilsson-Ehle P. Glomerular filtration rate in pregnancy: a study in normal subjects and in patients with hypertension, preeclampsia and diabetes. Scand J Clin Lab Invest 52: 387-392, 1992.8 w9 e7 @! e  H( C3 U$ S2 m. [; z. s

' B; S' N% V+ J+ s5 s- O3 ?$ ?

Lafayette RA, Druzin M, Sibley R, Derby G, Malik T, Huie P, Polhemus C, Deen WM, and Myers BD. Nature of glomerular dysfunction in pre-eclampsia. Kidney Int 54: 1240-1249, 1998.
; O0 R. |2 ^! e8 U1 I' g

Lafayette RA, Malik T, Druzin M, Derby G, and Myers BD. The dynamics of glomerular filtration after Caesarean section. J Am Soc Nephrol 10: 1561-1565, 1999., {* M5 l  s% h2 w4 s( E* U1 Y
( _& K. e. _+ m# q# U/ D% N1 ~

Lindeman RD, Tobin JD, and Shock NW. Association between blood pressure and the rate of decline in renal function with age. Kidney Int 26: 861-868, 1984.: d8 ?  ]! j8 z
) y% O) |: v) q$ i- e) ?  w

$ d& k/ S- Z+ P
Loon N, Shemesh O, Morelli E, and Myers BD. Effect of angiotensin II infusion on the human glomerular filtration barrier. Am J Physiol Renal Fluid Electrolyte Physiol 257: F608-F614, 1989.( F8 ]# c( ^8 |
$ p% D- Z1 _4 F+ p2 O$ d; {# Q
; `& H% T$ B) G% ]/ V

Magann EF and Martin JN Jr. Complicated postpartum preeclampsiaeclampsia. Obstet Gynecol Clin North Am 22: 337-356, 1995.7 J$ V: S: {0 }& B" z

9 o- @# f. l; [1 ~- C+ z
Magness RR, Cox K, Rosenfeld CR, and Gant NF. Angiotensin II metabolic clearance rate and pressor responses in nonpregnant and pregnant women. Am J Obstet Gynecol 171: 668-679, 1994.- A9 z3 e' q/ {5 _, G

, \8 X0 X( d2 ^8 X+ w) n, E
Magness RR, Osei-Boaten K, Mitchell MD, and Rosenfeld CR. In vitro prostacyclin production by ovine uterine and systemic arteries. Effects of angiotensin II. J Clin Invest 76: 2206-2212, 1985.2 m1 r5 J, W& d/ ]) E
- ~% S% w$ Q0 v9 S( L# a
0 v' W! V. v' U; B5 h
/ V$ I2 g- V' A9 S9 r& Y$ D# E
Miller PL and Meyer TW. Effects of tissue preparation on glomerular volume and capillary structure in the rat. Lab Invest 63: 862-866, 1990.8 f& r( ?% v  X- [) B% c& {) B
' k( w3 A! X( h5 }
6 ?8 b$ f$ J7 v, a$ p6 A. \# f+ v
' Y0 P# g6 u' c/ o
Milne JE, Lindheimer MD, and Davison JM. Glomerular heteroporous membrane modeling in third trimester and postpartum before and during amino acid infusion. Am J Physiol Renal Physiol 282: F170-F175, 2002.

0 E! v3 h/ c6 t+ R5 r7 o* V
& ]) R: W3 q! a8 X/ O
Moroni G, Quaglini S, Banfi G, Caloni M, Finazzi S, Ambroso G, Como G, and Ponticelli C. Pregnancy in lupus nephritis. Am J Kidney Dis 40: 713-720, 2002.- P# i/ X( l& c: g
) m. K' [' }) [/ V. a- @, j3 n

Nguyen HN, Clark SL, Greenspoon J, Diesfield P, and Wu PY. Peripartum colloid osmotic pressures: correlation with serum proteins. Obstet Gynecol 68: 807-810, 1986.# v( s9 S! S+ W9 N8 y1 m

: {1 e# s( R2 v9 D1 S

Nyengaard JR and Bendtsen TF. Glomerular number and size in relation to age, kidney weight, and body surface in normal man. Anat Rec 232: 194-201, 1992.( ~. g6 d4 \  o$ J; [) y6 p+ R

/ b9 l( P" }# p9 ?! L# B# c
. F) l# u& F/ l5 ]
Olufemi OS, Whittaker PG, Halliday D, and Lind T. Albumin metabolism in fasted subjects during late pregnancy. Clin Sci (Colch) 81: 161-168, 1991.' S, S, R6 M* j3 ~

) U$ r& |0 V9 S  ~5 e  x, M5 A7 @0 Y
2 Q, s6 [# y8 D* p- `' m
Paaby P. Changes in serum proteins during pregnancy. J Obstet Gynaecol Br Emp 67: 43-55, 1960.( e# K& ]3 U/ {

2 m. U- `2 {$ ^( @& H# E+ J
Ramsay M, Broughton Pipkin F, and Rubin P. Comparative study of pressor and heart rate responses to angiotensin II and noradrenaline in pregnant and non-pregnant women. Clin Sci (Colch) 82: 157-162, 1992.

# ]0 U1 ?; U) Y" ]! p% c

Roberts M, Lindheimer MD, and Davison JM. Altered glomerular permselectivity to neutral dextrans and heteroporous membrane modeling in human pregnancy. Am J Physiol Renal Fluid Electrolyte Physiol 270: F338-F343, 1996.( d1 T: ?* v' y7 ?& n

Sims EA and Krantz KE. Serial studies of renal function during pregnancy and the puerperium in normal women. J Clin Invest 37: 1764-1774, 1958.
$ B4 ?9 i6 p: K" |- E

' ~  [5 _1 |- c( U. p
Stockand JD and Sansom SC. Glomerular mesangial cells: electrophysiology and regulation of contraction. Physiol Rev 78: 723-744, 1998.

' y* b2 X6 I* @# N! p$ J7 K

Van Kreel BK, van Beek E, Spaanderman ME, and Peeters LL. A new method for plasma volume measurements with unlabeled dextran-70 instead of 125 I-labeled albumin as an indicator. Clin Chim Acta 275: 71-80, 1998.0 T- p" ^4 E+ m& n: F# s

Wahl EF, Lahdes-Vasama TT, and Churchill BM. Estimation of glomerular filtration rate and bladder capacity: the effect of maturation, ageing, gender and size. BJU Int 91: 255-262, 2003.+ ?5 m" T0 V' V& P
) u3 l/ g% e2 A! \

. `: ?8 r) [! C, U: S, l. F
Weibel ER. Sterological Methods: Practical Methods of Biological Morphometry. London, UK: Academic, 1979.$ l* U3 }# Y  V/ p8 Z
1 O$ n# r$ B8 r' m; z
7 u; E, B* P7 M' D: R  |

Werkö Bucht H and Josephson B. The renal extraction of para-aminohippuric acid and oxygen in man during postural changes of the circulation. Scand J Clin Lab Invest 1: 321-327, 1949.4 Q6 ]4 R# D6 Z+ |4 y  c9 x

/ x2 B! k: Y. I. N) R- g
Wesson LGJ. Renal hemodynamics in physiological states. In: Physiology of the Human Kidney. New York: Grune and Stratton, 1969, p. 96-108.

作者: foxok 时间: 2015-5-26 12:33

楼主good

作者: 舒思 时间: 2015-6-14 10:01

希望可以用些时间了~````

作者: 剑啸寒 时间: 2015-7-9 17:32

越办越好~~~~~~~~~`

作者: 龙水生 时间: 2015-7-17 11:44

顶下再看

作者: 石头111 时间: 2015-8-6 23:32

顶你一下.

作者: immail 时间: 2015-8-10 12:56

又看了一次

作者: biobio 时间: 2015-9-3 18:17

我帮你喝喝

作者: 红旗 时间: 2015-9-8 11:54

初来乍到，请多多关照。。。嘿嘿，回个贴表明我来过。

作者: awen 时间: 2015-9-17 18:32

…没我说话的余地…飘走

作者: laoli1999 时间: 2015-9-21 16:16

希望大家帮我把这个帖发给你身边的人，谢谢！

作者: beautylive 时间: 2015-9-22 16:26

支持一下

作者: awen 时间: 2015-10-22 15:35

dddddddddddddd

作者: foxok 时间: 2015-11-21 12:53

挤在北京，给首都添麻烦了……

作者: 罗马星空 时间: 2015-11-30 11:01

照你这么说真的有道理哦呵呵不进沙子馁~~~

作者: 昕昕 时间: 2015-12-5 09:54

一个有信念者所开发出的力量，大于99个只有兴趣者。

作者: aakkaa 时间: 2015-12-9 15:43

孜孜不倦，吾等楷模 …………

作者: 剑啸寒 时间: 2015-12-9 21:27

细胞治疗行业

作者: 罗马星空 时间: 2015-12-11 10:33

这个贴好像之前没见过

作者: 杏花 时间: 2015-12-30 21:43

初来乍到，请多多关照。。。

作者: nauticus 时间: 2016-1-12 21:27

这个贴不错！！！！！

作者: 剑啸寒 时间: 2016-1-19 14:10

继续查找干细胞研究资料

作者: awen 时间: 2016-1-25 19:43

哈哈我支持你

作者: 橙味绿茶 时间: 2016-2-1 18:24

说的真有道理啊！

作者: foxok 时间: 2016-3-13 19:18

干细胞与动物克隆

作者: netlover 时间: 2016-3-18 15:24

楼主福如东海，万寿无疆！

作者: xm19 时间: 2016-3-20 14:43

勤奋真能造就财富吗？

作者: 罗马星空 时间: 2016-3-23 20:33

不错不错.,..我喜欢

作者: 小倔驴 时间: 2016-4-21 08:35

转基因动物

作者: MIYAGI 时间: 2016-4-29 10:54

支持你一下下。。

作者: bluesuns 时间: 2016-5-13 13:10

这个贴不错！！！！！

作者: xiao2014 时间: 2016-5-15 11:18

对不起，我走错地方了，呵呵

作者: dmof 时间: 2016-5-17 12:54

进行溜达一下

作者: 考拉 时间: 2016-5-29 17:17

干细胞研究还要面向临床

作者: 生物小菜鸟 时间: 2016-6-24 17:00

我仅代表干细胞之家论坛前来支持，感谢楼主！

作者: 苹果天堂 时间: 2016-6-29 15:43

原来这样也可以

作者: happyboy 时间: 2016-7-6 09:02

哈哈，看的人少，回一下

作者: 三好学生 时间: 2016-7-12 22:20

赚点分不容易啊

作者: beautylive 时间: 2016-7-25 22:16

顶你一下，好贴要顶！

作者: 某某人 时间: 2016-9-17 13:27

努力,努力,再努力!!!!!!!!!!!

作者: 修复者 时间: 2016-9-18 11:42

这贴？不回都不行啊

作者: 心仪 时间: 2016-10-3 12:07

一楼的位置好啊..

作者: 365wy 时间: 2016-10-12 09:01

不早了各位晚安~~~~

作者: 我心飞翔 时间: 2016-10-22 20:38

今天再看下

作者: 刘先生 时间: 2016-10-23 15:54

都是那么过来的

作者: tuting 时间: 2016-10-29 12:10

勤奋真能造就财富吗？

作者: 快乐小郎 时间: 2016-11-15 12:54

我来了~~~~~~~~~ 闪人~~~~~~~~~~~~~~~~

作者: dreamenjoyer 时间: 2016-11-26 10:43

好啊，谢楼主

作者: dogcat 时间: 2016-11-27 17:35

文笔流畅，修辞得体，深得魏晋诸朝遗风，更将唐风宋骨发扬得入木三分，能在有生之年看见楼主的这个帖子。实在是我三生之幸啊。

作者: 锦锦乐道 时间: 2016-12-16 11:27

厉害！强~~~~没的说了！

作者: 追风 时间: 2016-12-25 05:34

真是天底下好事多多

作者: hmhy 时间: 2016-12-26 22:43

细胞治疗行业

作者: dr_ji 时间: 2016-12-31 10:54

加油啊！！！！顶哦!!!!!

作者: 心仪 时间: 2017-1-12 00:25

顶的就是你

作者: foxok 时间: 2017-3-7 01:35

慢慢来，呵呵

作者: 墨玉 时间: 2017-3-9 18:18

我在顶贴~！~

作者: happyboy 时间: 2017-3-28 18:26

干细胞治疗糖尿病

作者: tuting 时间: 2017-3-30 08:27

呵呵高高实在是高~~~~~

作者: keanuc 时间: 2017-3-31 22:40

我好想升级

作者: www1202000 时间: 2017-4-3 19:01

祝干细胞之家越办越好~~~~~~~~~`

作者: netlover 时间: 2017-4-17 23:49

今天再看下

作者: 大小年 时间: 2017-6-2 05:26

神经干细胞

作者: yukun 时间: 2017-6-6 03:53

怎么就没人拜我为偶像那?? ~

作者: awen 时间: 2017-6-21 01:35

继续查找干细胞研究资料

作者: biodj 时间: 2017-6-23 19:23

干细胞与动物克隆

作者: 我心飞翔 时间: 2017-8-2 03:25

回复一下

作者: 安生 时间: 2017-8-7 06:56

非常感谢楼主，楼主万岁万岁万万岁！

作者: vsill 时间: 2017-8-9 22:52

我等你哟!

作者: lalala 时间: 2017-8-11 07:52

干细胞行业门户干细胞之家

作者: renee 时间: 2017-8-11 08:43

不对，就是碗是铁的，里边没饭你吃啥去？

作者: biobio 时间: 2017-8-18 17:32

努力,努力,再努力!!!!!!!!!!!

作者: qibaobao 时间: 2017-9-3 20:54

给我一个女人，我可以创造一个民族；给我一瓶酒，我可以带领他们征服全世界。。。。。。。。。

作者: whyboy 时间: 2017-11-14 22:47

呵呵大家好奇嘛来观看下~~~~

作者: 化药所 时间: 2017-11-30 23:15

我想要`~

作者: doc2005 时间: 2017-12-4 21:15

谢谢分享了!

作者: 快乐小郎 时间: 2017-12-12 10:18

一个子没看懂

作者: 旅美学者 时间: 2017-12-18 20:50

内皮祖细胞

作者: cjms 时间: 2017-12-22 10:27

努力~~各位。。。

作者: 未必温暖 时间: 2017-12-30 09:01

很好！很强大！

作者: 心仪 时间: 2018-1-2 20:55

呵呵哪天得看看 `~~~~

作者: ikiss 时间: 2018-1-4 00:54

慢慢来，呵呵

作者: 舒思 时间: 2018-1-9 13:53

HOHO~~~~~~

作者: 分子工程师 时间: 2018-1-9 23:35

谢谢分享了!

作者: lalala 时间: 2018-1-19 13:52

好贴子好多啊

作者: dmof 时间: 2018-1-20 05:24

一楼的位置好啊..

作者: syt7000 时间: 2018-1-20 12:01

先看看怎么样！

作者: mk990 时间: 2018-1-23 21:00

很好！很强大！

作者: doors 时间: 2018-1-25 10:10

干细胞之家

作者: Whole 时间: 2018-1-27 22:10

不要等到人人都说你丑时才发现自己真的丑。

作者: 蝶澈 时间: 2018-2-5 13:16

想都不想，就支持一下

作者: feixue66 时间: 2018-2-7 20:58

帮你项项吧

作者: highlight 时间: 2018-2-11 13:34

回复一下

作者: 化药所 时间: 2018-2-14 11:01

支持你一下下。。

作者: yunshu 时间: 2018-3-30 02:52

哈哈瞧你说的~~~

作者: Diary 时间: 2018-3-31 07:28

今天临床的资料更新很多呀

作者: 一个平凡人 时间: 2018-4-3 11:35

顶一个先

作者: renee 时间: 2018-4-4 09:10

(*^__^*) 嘻嘻……

作者: 干细胞2014 时间: 2018-4-20 03:56

免疫细胞疗法治疗肿瘤有效

作者: abc987 时间: 2018-4-20 04:58

宁愿选择放弃，不要放弃选择。

作者: whyboy 时间: 2018-4-24 13:35

顶你一下.

欢迎光临干细胞之家 - 中国干细胞行业门户第一站 (http://stemcell8.cn/)